A PROSPECTIVE REGISTRY TO ASSESS THE EFFECTIVENESS AND LOCAL TOLERABILITY OF INTRAVESICAL VALRUBICIN IN SUBJECTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)

Endo Pharmaceuticals10 sites in 1 country15 target enrollmentStarted: May 2011Last updated: June 12, 2015

Conditions

Trial Snapshot

Phase: Not Applicable
Status: Terminated
Sponsor
Enrollment: 15
Locations: 10

Study Overview Study Design Eligibility Criteria Investigators Sites Records & Identifiers Similar Trials

Study Overview

Brief Summary

The purpose of this study is to observe and describe the effectiveness and local tolerability of intravesical treatment with valrubicin for non-muscle invasive bladder cancer (NMIBC) in a cohort of subjects treated under routine practice conditions.

Study Design

Study Type: Observational
Time Perspective: Prospective

Eligibility Criteria

Ages: 18 Years to — (Adult, Older Adult)
Sex: All
Accepts Healthy Volunteers: No

Inclusion Criteria

•Males and females 18 years of age and older
•Diagnosed with NMIBC
•Prescribed intravesical valrubicin to treat NMIBC
•Understood and signed Informed Consent to participate

Exclusion Criteria

Not provided

Investigators

Sponsor

Endo Pharmaceuticals

Sponsor Class

Industry

Responsible Party

Sponsor

Study Sites (10)

Loading locations...

Similar Trials

Completed

Not Applicable

Feasibility of M-health Version of "What Were We Thinking" Intervention to Promote Maternal Postpartum Mental HealthDepression, PostpartumAnxiety Disorders and SymptomsMaternal Behavior

NCT04847076Universidad del Desarrollo128

Withdrawn

Not Applicable

Observational Prospective Registry of the Efficacy, Safety, and Adherence to Infergen® in Patients Infected With Hep CHepatitis C

NCT00951223Kadmon Corporation, LLC

Completed

Not Applicable

Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.Heroin Addiction

NCT02062736L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.500

Completed

Phase 1

Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.ymphedema and lymphatic disease, chylous thoracs and ascites

JPRN-UMIN000021762Saiseikai Kawaguchi General Hospital200

Completed

Phase 1

Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease.ymphedema and lymphatic disease

JPRN-UMIN000022973Saiseikai Kawaguchi General Hospital. Department of lymphatic and reconstructive surgery.200